Atmin is a tumor suppressor gene in lung adenocarcinoma

Hanna Foster; E. Josue Ruiz; Christopher Moore; Gordon W.H. Stamp; Emma L. Nye; Ningning Li; Yihang Pan; Yulong He; Julian Downward; Axel Behrens

doi:10.1158/0008-5472.CAN-19-0647

Atmin is a tumor suppressor gene in lung adenocarcinoma

Hanna Foster, E. Josue Ruiz, Christopher Moore, Gordon W.H. Stamp, Emma L. Nye, Ningning Li, Yihang Pan, Yulong He, Julian Downward, Axel Behrens^*

^*Corresponding author for this work

Diabetes

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

Tumor cells proliferate rapidly and thus are frequently subjected to replication stress and the risk of incomplete duplication of the genome. Fragile sites are replicated late, making them more vulnerable to damage when DNA replication fails to complete. Therefore, genomic alterations at fragile sites are commonly observed in tumors. FRA16D is one of the most common fragile sites in lung cancer, however, the nature of the tumor suppressor genes affected by FRA16D alterations has been controversial. Here, we show that the ATMIN gene, which encodes a cofactor required for activation of ATM kinase by replication stress, is located close to FRA16D and is commonly lost in lung adenocarcinoma. Low ATMIN expression was frequently observed in human lung adenocarcinoma tumors and was associated with reduced patient survival, suggesting that ATMIN functions as a tumor suppressor in lung adenocarcinoma. Heterozygous Atmin deletion significantly increased tumor cell proliferation, tumor burden, and tumor grade in the LSL-KRasG12D; Trp53 F/F (KP) mouse model of lung adenocarcinoma, identifying ATMIN as a haploinsufficient tumor suppressor. ATMIN-deficient KP lung tumor cells showed increased survival in response to replication stress and consequently accumulated DNA damage. Thus, our data identify ATMIN as a key gene affected by genomic deletions at FRA16D in lung adenocarcinoma.

Original language	English
Pages (from-to)	5159-5166
Number of pages	8
Journal	Cancer Research
Volume	79
Issue number	20
DOIs	https://doi.org/10.1158/0008-5472.CAN-19-0647
Publication status	Published - 15 Oct 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-19-0647

Cite this

@article{17424a5509524bd9a83da9713bc9277f,

title = "Atmin is a tumor suppressor gene in lung adenocarcinoma",

abstract = "Tumor cells proliferate rapidly and thus are frequently subjected to replication stress and the risk of incomplete duplication of the genome. Fragile sites are replicated late, making them more vulnerable to damage when DNA replication fails to complete. Therefore, genomic alterations at fragile sites are commonly observed in tumors. FRA16D is one of the most common fragile sites in lung cancer, however, the nature of the tumor suppressor genes affected by FRA16D alterations has been controversial. Here, we show that the ATMIN gene, which encodes a cofactor required for activation of ATM kinase by replication stress, is located close to FRA16D and is commonly lost in lung adenocarcinoma. Low ATMIN expression was frequently observed in human lung adenocarcinoma tumors and was associated with reduced patient survival, suggesting that ATMIN functions as a tumor suppressor in lung adenocarcinoma. Heterozygous Atmin deletion significantly increased tumor cell proliferation, tumor burden, and tumor grade in the LSL-KRasG12D; Trp53 F/F (KP) mouse model of lung adenocarcinoma, identifying ATMIN as a haploinsufficient tumor suppressor. ATMIN-deficient KP lung tumor cells showed increased survival in response to replication stress and consequently accumulated DNA damage. Thus, our data identify ATMIN as a key gene affected by genomic deletions at FRA16D in lung adenocarcinoma.",

author = "Hanna Foster and {Josue Ruiz}, E. and Christopher Moore and Stamp, {Gordon W.H.} and Nye, {Emma L.} and Ningning Li and Yihang Pan and Yulong He and Julian Downward and Axel Behrens",

year = "2019",

month = oct,

day = "15",

doi = "10.1158/0008-5472.CAN-19-0647",

language = "English",

volume = "79",

pages = "5159--5166",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "20",

}

TY - JOUR

T1 - Atmin is a tumor suppressor gene in lung adenocarcinoma

AU - Foster, Hanna

AU - Josue Ruiz, E.

AU - Moore, Christopher

AU - Stamp, Gordon W.H.

AU - Nye, Emma L.

AU - Li, Ningning

AU - Pan, Yihang

AU - He, Yulong

AU - Downward, Julian

AU - Behrens, Axel

PY - 2019/10/15

Y1 - 2019/10/15

N2 - Tumor cells proliferate rapidly and thus are frequently subjected to replication stress and the risk of incomplete duplication of the genome. Fragile sites are replicated late, making them more vulnerable to damage when DNA replication fails to complete. Therefore, genomic alterations at fragile sites are commonly observed in tumors. FRA16D is one of the most common fragile sites in lung cancer, however, the nature of the tumor suppressor genes affected by FRA16D alterations has been controversial. Here, we show that the ATMIN gene, which encodes a cofactor required for activation of ATM kinase by replication stress, is located close to FRA16D and is commonly lost in lung adenocarcinoma. Low ATMIN expression was frequently observed in human lung adenocarcinoma tumors and was associated with reduced patient survival, suggesting that ATMIN functions as a tumor suppressor in lung adenocarcinoma. Heterozygous Atmin deletion significantly increased tumor cell proliferation, tumor burden, and tumor grade in the LSL-KRasG12D; Trp53 F/F (KP) mouse model of lung adenocarcinoma, identifying ATMIN as a haploinsufficient tumor suppressor. ATMIN-deficient KP lung tumor cells showed increased survival in response to replication stress and consequently accumulated DNA damage. Thus, our data identify ATMIN as a key gene affected by genomic deletions at FRA16D in lung adenocarcinoma.

AB - Tumor cells proliferate rapidly and thus are frequently subjected to replication stress and the risk of incomplete duplication of the genome. Fragile sites are replicated late, making them more vulnerable to damage when DNA replication fails to complete. Therefore, genomic alterations at fragile sites are commonly observed in tumors. FRA16D is one of the most common fragile sites in lung cancer, however, the nature of the tumor suppressor genes affected by FRA16D alterations has been controversial. Here, we show that the ATMIN gene, which encodes a cofactor required for activation of ATM kinase by replication stress, is located close to FRA16D and is commonly lost in lung adenocarcinoma. Low ATMIN expression was frequently observed in human lung adenocarcinoma tumors and was associated with reduced patient survival, suggesting that ATMIN functions as a tumor suppressor in lung adenocarcinoma. Heterozygous Atmin deletion significantly increased tumor cell proliferation, tumor burden, and tumor grade in the LSL-KRasG12D; Trp53 F/F (KP) mouse model of lung adenocarcinoma, identifying ATMIN as a haploinsufficient tumor suppressor. ATMIN-deficient KP lung tumor cells showed increased survival in response to replication stress and consequently accumulated DNA damage. Thus, our data identify ATMIN as a key gene affected by genomic deletions at FRA16D in lung adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85073306741&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-19-0647

DO - 10.1158/0008-5472.CAN-19-0647

M3 - Article

C2 - 31481498

AN - SCOPUS:85073306741

SN - 0008-5472

VL - 79

SP - 5159

EP - 5166

JO - Cancer Research

JF - Cancer Research

IS - 20

ER -

Atmin is a tumor suppressor gene in lung adenocarcinoma

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this